Just as effective as the high dose, low-dose apixaban prevents long-term recurrent venous thromboembolism in patients with ...

Oral semaglutide, already approved for type 2 diabetes, led to a reduction in CV events in patients with established ...

The GLP-1 agonist has shown convincing benefits in yet another population, patients with peripheral arterial disease, in a ...

Advances in PCI over the past decade mean the procedure can now approximate results only previously achieved with open-heart bypass surgery, new data show.

A show of hands at the ACC town hall demonstrated unity as specialists investigate options for a new certifying board outside the current one or with two parent sponsors.

The US Food and Drug Administration has approved fitusiran for bleeding prophylaxis in hemophilia A and B with or without ...

The addition of the aldosterone synthase inhibitor helped lower blood pressure in patients with resistant hypertension.

A Northwestern medical student has found a better way of measuring someone's heart health by smartwatch using a formula of ...

Varied approaches to remote patient monitoring are in development to close care gaps between patients and rheumatologists, ...

Pediatricians must disclose adverse events and medical errors to children and their families, according to an updated policy ...

Researchers identified patients with stage I-III TNBC diagnosed between 2010 and 2021 and assessed trends in NACT use, ...

In a retrospective cohort study, ustekinumab and guselkumab show trends toward lower risk for herpes zoster in patients with ...